-
PINK1 Activators for Treating Parkinson's Disease
… PINK1 activity in cells thereby promoting mitochondrial health. Our ultimate goal is to study the therapeutic effect … progression of Parkinson’s disease. Such a therapy can fundamentally change the way PD is treated. Next Steps for …
-
Easing Into Retirement with Parkinson’s
October 8, 2025
… how to retire as they balance symptoms, their financial and health needs and their plans and interests. Tune into this …
-
Unified Parkinson's Advocacy Council
… organizations, to positively impact research and health care policy. In June 2016, PAN closed its doors and …
-
Genetically Encoded Fluorescent Biosensors for Live-cell, Subcellular Detection of Distinct α-synuclein Aggregation States
… Alpha-synuclein (aSYN) is a critical protein in health and Parkinson’s disease (PD). aSYN has a soluble form … establish cell- and animal-based assays to evaluate environmental/genetic factors and drug candidates influencing and …
-
Identification of the Parkin-binding Domain for SLP-2 as a Potential Therapeutic Target Supplement
… We believe this interaction is important for maintaining healthy mitochondria and thus set out to examine the effects … in iPSC-derived neurons of patients. Objectives for Supplemental Investigation: Based on the results … carriers and see whether this helps restore mitochondrial health. We would like to investigate whether small fragments …
-
Ask the PhD: Parkinson's and the Microbiome
May 7, 2019
… brain cells). Due to its size, complexity and influence on health, the microbiome is sometimes referred to as a … medications targeting ghrelin and LRRK2. What’s Next? Fundamental questions remain unanswered about the microbiome and … and can we measure it? What is in the gut microbiome of healthy people that’s different from people with …